Results 51 to 60 of about 1,536 (210)

Look Outside the Brain: Incidentally Detected Cutis Verticis Gyrata. [PDF]

Clin Case Rep
ABSTRACT Cutis verticis gyrata (CVG) is a rare dermatological condition characterized by thickened and folded scalp skin, often discovered incidentally during neuroimaging for unrelated issues. Clinicians should remain vigilant and consider a multidisciplinary approach to recognize and manage potential comorbidities, emphasizing the importance of a ...
Devkota S, Bhatta OP.
europepmc   +2 more sources

Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature

Clinical Case Reports, 2020
Scleromyxedema is a rare and progressive disease that currently has no standard treatment. Triplet therapy with lenalidomide, bortezomib, and dexamethasone can be an effective therapy for scleromyxedema, especially in patients with refractory or relapsed
Hninyee Win, Krisstina Gowin
doaj   +1 more source

Clinical applications of immunoglobulin in neuromuscular diseases: focus on inflammatory myopathies [PDF]

, 2014
During recent years, an increasing number of neuromuscular diseases have been recognized either to be caused primarily by autoimmune mechanisms, or to have important autoimmune components.
Oliveira, Acary Souza Bulle, Pinto, Wladimir Bocca Vieira de Rezende, Souza, Paulo Victor Sgobbi de   +2 more
core   +3 more sources

A Case of Multiple Myeloma Diagnosed by Skin Lesions [PDF]

, 2010
Multiple myeloma, being a malignant proliferation of plasma cells in the bone marrow, has clinical spectrum varying from monoclonal gammopathy with unknown significance to plasma cell leukemia.
Aylin Okçu Heper, Aysel Gürler, Burcu Tuğrul, Fatma Gülru Erdoğan   +3 more
core   +1 more source

Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: A systematic review [PDF]

, 2012
Glatiramer acetate and interferon-beta are approved first-line disease-modifying treatments (DMTs) for multiple sclerosis (MS). DMTs can be associated with cutaneous adverse events, which may influence treatment adherence and patient quality of life.
Alava C, Batista J, Bayerl C, Debat Zoguereh D, Devonshire V, Dimov V, Gaudez C, Heinzerling L, Kaiser C, Madray M, Nakamura Y, Navne JE, Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years, Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis, Poulin F, Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis, Rio J, Sanchez-Lopez J, Weinberg JM, Yang CH, Ziegler VR   +20 more
core   +1 more source

Plasma cell myeloma masquerading as scleromyxedema

Indian Dermatology Online Journal, 2019
Scleromyxedema is a rare progressive cutaneous mucinosis of unknown etiology with equal prevalence in both men and women. It is usually associated with monoclonal gammopathy in most of the cases.
Varun Victor, Rashmi Maria Margareat
doaj   +1 more source

Immunologic and nonimmunologic sclerodermal skin conditions - review

Frontiers in Immunology, 2023
Scleroderma-like cutaneous lesions have been found in many pathological conditions and they have the clinical appearance of sclerotic or scleroatrophic lesions.
Carmen Bobeica, Elena Niculet, Elena Niculet, Mihaela Craescu, Mihaela Craescu, Elena-Laura Parapiru, Andreea Mioara Corduneanu-Luca, Mihaela Debita, Ana Maria Pelin, Carmen Tiutiuca, Claudiu Ionut Vasile, Alin Codrut Nicolescu, Magdalena Miulescu, Gabriela Balan, Gabriela Balan, Alin Laurentiu Tatu, Alin Laurentiu Tatu, Alin Laurentiu Tatu   +17 more
doaj   +1 more source

A rare case of tumoral scleromyxedema

Indian Journal of Dermatology, 2020
Scleromyxedema is an uncommon disease, affecting the skin mainly and other internal organs sometimes, characterized by fibroblasts proliferation, fibrosis, and mucous deposition in the absence of thyroid disorder.
Ali Sadeghinia, Mohammad Al Salman, Jafar Taghizadeh Fazli, Pedram Normohammadpour, Amir Hooshang Ehsani, Seyed Naser Emadi   +5 more
doaj   +1 more source

Case for diagnosis. Lichen myxedematosus [PDF]

Anais Brasileiros de Dermatologia, 2016
Scleromyxedema or lichen myxedematosus is a rare papular mucinosis of chronic and progressive course and unknown etiology. It is commonly associated with monoclonal gammopathy and may show extracutaneous manifestations, affecting the heart, lung, kidney,
Priscila Regina Orso Rebellato, Mauren Beatriz Frazon Carbonar, Nicole Iasmin Magario Tabuti, Graziela Junges Crescente Rastelli   +3 more
doaj   +1 more source

Scleromyxedema without internal malignancy – A case report and review

Journal of Integrated Health Sciences, 2016
Scleromyxedema is a chronic, progressive condition characterized by confluent lichenoid eruption. It is usually associated with paraproteinemia. We present the case of 52 years old man diagnosed scleromyxedema without malignancy and paraproteinemia and ...
P K Shekhat, R Mahajan, I A Pandya, F E Bilimoria   +3 more
doaj   +1 more source